Michelle Roh, Ph.D., M.P.H.

  • Assistant Professor of Obstetrics and Gynecology, School of Medicine

Biography

Michelle Roh is an Assistant Professor in the Department of Obstetrics and Gynecology at Oregon Health & Science University and affiliate member of the UC San Francisco Malaria Elimination Initiative. Her research focuses on identifying and evaluating effective malaria chemoprevention strategies to inform global policies directed at improving maternal and child health. Her work utilizes a combination of field studies and modern causal inference methods to strengthen evaluations of malaria interventions, elucidate underlying disease mechanisms, and generate evidence that is both generalizable and policy-relevant.

Education and training

  • Degrees

    • Ph.D., 2020, University of California San Francisco
    • M.P.H., 2015, Yale School of Public Health
    • B.S., 2010, University of California San Diego

Areas of interest

  • Malaria
  • Antimalarial therapies
  • Pregnancy outcomes
  • Global health
  • Epidemiological methods
  • Causal inference

Additional information

Honors and awards

  • Vittinghoff Innovation Award, 2020, University of California San Francisco
  • Earle C. Anthony Social Sciences Fellowship, 2016-2017, University of California San Francisco
  • Charles and Agnes Talar Scholarship, 2015, Yale School of Public Health
  • Wilbur G. Downs International Health Fellowship, 2014-2015, Yale School of Public Health

Publications

Selected publications

  • FocaL mass drug Administration for Plasmodium vivax Malaria Elimination (FLAME): study protocol for an open-label cluster randomized controlled trial in Peru. Trials. 2025 Oct 14;26(1):408. doi: 10.1186/s13063-025-09112-1. Fine S, Quiroz AA, Calle VS, Manrique P, Rodriguez H, Carrasco G, Benjamin-Chung J, Bennett A, Auburn S, Price R, Greenhouse B, Baird JK, Domingo G, Roh M, Rosas A, Llanos-Cuentas A, Hsiang M. PMID: 40321759; PMCID: PMC12047980.
  • Using transportability methods to map the local effectiveness of mass drug administration for malaria in Senegal. medRxiv. 2025 Aug 13. Roh ME, Tong Y, Heitmann GB, Ba EKC, Ndiaye JL, Fogelson A, Milligan P, Seck A, Diallo A, Lo AC, Baiocchi M, Gosling R, Bennett A, Hsiang MS, Benjamin-Chung J. 
  • Impact of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine on sexually transmitted and reproductive tract infections: results from a randomised trial in Uganda. medRxiv. 2025 Jul 03. Adrama H, Dela Cruz EJ, Ozarslan N, Kakuru A, Odongo B, Gaw SL, Benjamin-Chung J, Kizza J, Aguti M, Ategeka J, Olwoch P, Nakalembe M, Opira B, Clark TD, Kamya MR, Rosenthal PJ, Dorsey G, Roh ME. 
  • Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data meta-analysis. EClinicalMedicine. 2025 May; 83:103202. Roh ME*, Gutman JR*, Murphy M, Hill J, Madanitsa M, Kakuru A, Barsosio HC, et al. 
  • Effect of mass drug administration on malaria incidence in southeast Senegal during 2020-22: a two-arm, open-label, cluster-randomised controlled trial. Lancet Infect Dis. 2025 Jun; 25(6):656-667. Ba EKC*, Roh ME*, Diallo A, Gadiaga T, Seck A, Thiam S, Fogelson A, Gaye S, Diallo I, Lo AC, Diouf E, Ba OG, Gueye AB, Wu X, Milligan P, ..., Hsiang MS, Ndiaye JL. 
  • Drug-Drug Interaction Between Dihydroartemisinin-Piperaquine and Sulfadoxine-Pyrimethamine During Malaria Chemoprevention in Pregnant Women. Clin Pharmacol Ther. 2025 Feb; 117(2):506-514. Mwebaza N*, Roh ME*, Geng YZ, Opio L, Opira B, Marzan F, Mwima MW, Ssemukuye T, Guo K, Gingrich D, Fotaki N, Kakuru A, Kizza J, Aguti M, Adrama H, Kamya M, Dorsey G, Rosenthal PJ, Aweeka FT, Huang L. 
  • Association between indoor residual spraying and pregnancy outcomes: a quasi-experimental study from Uganda. Int J Epidemiol. 2022 10 13; 51(5):1489-1501. Roh ME, Mpimbaza A, Oundo B, Irish A, Murphy M, Wu SL, White JS, Shiboski S, Glymour MM, Gosling R, Dorsey G, Sturrock H. 
  • A quasi-experimental study estimating the impact of long-lasting insecticidal nets with and without piperonyl butoxide on pregnancy outcomes. Malar J. 2022 Jan 04; 21(1):5. Roh ME, Oundo B, Dorsey G, Shiboski S, Gosling R, Glymour MM, Staedke SG, Bennett A, Sturrock H, Mpimbaza A. 
  • Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis. Lancet Glob Health. 2020 07; 8(7):e942-e953. Roh ME, Kuile FOT, Rerolle F, Glymour MM, Shiboski S, Gosling R, Gutman J, Kakuru A, Desai M, Kajubi R, L'Ianziva A, Kamya MR, Dorsey G, Chico RM. 
  • High Genetic Diversity of Plasmodium falciparum in the Low-Transmission Setting of the Kingdom of Eswatini. J Infect Dis. 2019 09 13; 220(8):1346-1354. Roh ME, Tessema SK, Murphy M, Nhlabathi N, Mkhonta N, Vilakati S, Ntshalintshali N, Saini M, Maphalala G, Chen A, Wilheim J, Prach L, Gosling R, Kunene S, S Hsiang M, Greenhouse B.